cyclo-tetra-glucose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cycloalternan: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyclobis-(1->6)-alpha-nigerosyl : A cyclic tetrasaccharide constructed from four alpha-glucopyranosyl residues joined by alternate alpha-(1->6)- and alpha-(1->3)-linkages. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID Source	ID
PubMed CID	11686063
CHEBI ID	136822
MeSH ID	M0380150

Synonyms (28)

Synonym
cyclobis-(1->6)-alpha-nigerosyl
CHEBI:136822
cyclobis-(1->3)-alpha-isomaltosyl
cyclic nigerosylnigerose
cyclotetraglucose [inci]
alpha-d-glucopyranose, o-alpha-d-glucopyranosyl-(1-3)-o-alpha-d-glucopyranosyl-(1-6)-o-alpha-d-glucopyranosyl-(1-3)-, cyclic 1,6'''-anhydride
ct-11
cyclotetraglucose
80as740c52 ,
unii-80as740c52
cycloalternan
159640-28-5
ins no.1504(i)
ins no.1504(ii)
.alpha.-d-glucopyranose, o-.alpha.-d-glucopyranosyl-(1-3)-o-.alpha.-d-glucopyranosyl-(1-6)-o-.alpha.-d-glucopyranosyl-(1-3)-, cyclic 1,6'''-anhydride
e-1504(ii)
ins-1504(ii)
cycloalternanotetraose
ins-1504(i)
cyclic nigerosyl-(1->6)-nigerose
cyclotetraose
e-1504(i)
DTXSID70166703
C21655
cyclobis-1,6-alpha-nigerosyl
(1r,3s,4r,5r,7s,10r,11s,12s,13r,14r,16s,17r,18r,20s,23r,24s,25s,26r,28r,30r)-5,18-bis(hydroxymethyl)-2,6,8,15,19,21,27,29-octaoxapentacyclo[21.3.1.13,7.110,14.116,20]triacontane-4,11,12,13,17,24,25,26,28,30-decol
Q27269133
\|a-d-glucopyranose, o-\|a-d-glucopyranosyl-(1 inverted exclamation marku3)-o-\|a-d-glucopyranosyl-(1 inverted exclamation marku6)-o-\|a-d-glucopyranosyl-(1 inverted exclamation marku3)-, cyclic 1,6'''-anhydride

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

Class	Description
macrocycle	A cyclic compound containing nine or more atoms as part of the cyclic system.
tetrasaccharide	An oligosaccharide comprising four monomeric monosaccharide units.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

Pathway	Proteins	Compounds
cyclobis-(1u21926)-u03B1-nigerosyl degradation	1	5

Research

Studies (13)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (23.08)	29.6817
2010's	7 (53.85)	24.3611
2020's	3 (23.08)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.06 (24.57)
Research Supply Index	2.71 (2.92)
Research Growth Index	4.77 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.06)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	1 (7.69%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	12 (92.31%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
hydrogen Hydrogen: The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.. dihydrogen : An elemental molecule consisting of two hydrogens joined by a single bond.	3.7	1	1	elemental hydrogen; elemental molecule; gas molecular entity	antioxidant; electron donor; food packaging gas; fuel; human metabolite
methanol Methanol: A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.. primary alcohol : A primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.. methanol : The primary alcohol that is the simplest aliphatic alcohol, comprising a methyl and an alcohol group.	2.11	1	0	alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound	amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
sucrose Saccharum: A plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.	2.41	1	0	glycosyl glycoside	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent
pyromellitic acid pyromellitic acid: RN given refers to parent cpd; structure. pyromellitic acid : A tetracarboxylic acid that is benzene substituted by four carboxy groups at positions 1, 2, 4 and 5 respectively.	2.11	1	0	benzoic acids; tetracarboxylic acid
glucosamine D-glucosamine : An amino sugar whose structure comprises D-glucose having an amino substituent at position 2.. 2-amino-2-deoxy-D-glucopyranose : A D-glucosamine whose structure comprises D-glucopyranose having an amino substituent at position 2.	2.15	1	0	D-glucosamine	Escherichia coli metabolite; geroprotector; mouse metabolite
maltodextrin maltodextrin : A dextrin in which the D-glucose units are linked by alpha-(1->4) glycosidic bonds.	2.01	1	0

Condition	Relationship Strength	Studies
Innate Inflammatory Response [description not available]	2.6	1
Insulin Sensitivity [description not available]	2.6	1
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.	2.6	1
Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.	2.6	1
Hypomelanosis [description not available]	2.15	1
B16 Melanoma [description not available]	2.15	1
Hypopigmentation A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.	2.15	1

chemdatabank.com